• Rohit @rohit66 ·  6 years, 5 months ago  ·
    Added DIVISLAB to watchlist
    The company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports.
    Unattractive Valuation Sales Growth > 10% Profit Margin > 15% NIFTY 50 + 20 indices
 
Reply to @rohit66
Use @ for users, # for companies and : for emojis
Relevant Companies
Mentioned Users
Trending Today
Leaderboard View more / less  
Loading..
Top Gainers & Losers View more / less
Loading ...